Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

ClinicalTrials.gov ID: NCT04757610

Public ClinicalTrials.gov record NCT04757610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 8:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Ranibizumab, Compared With Ranibizumab Alone, in Participants With nAMD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 2-year, phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

Study identification

NCT ID
NCT04757610
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Opthea Limited
Industry
Enrollment
986 participants

Conditions and interventions

Interventions

Biological · Procedure

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2021
Primary completion
Mar 30, 2025
Completion
Mar 30, 2025
Last update posted
Jul 21, 2025

2021 – 2025

United States locations

U.S. sites
76
U.S. states
24
U.S. cities
70
Facility City State ZIP Site status
ShORe Investigational Site Phoenix Arizona 85016
ShORe Investigational Site Phoenix Arizona 85050
ShORe Investigational Site Tucson Arizona 85704
ShORe Investigational Site Bakersfield California 93309
ShORe Investigational Site Campbell California 95008
ShORe Investigational Site Encino California 91436
ShORe Investigational Site Fullerton California 92835
ShORe Investigational Site Glendale California 91203
ShORe Investigational Site Huntington Beach California 92647
ShORe Investigational Site Laguna Hills California 92653
ShORe Investigational Site Long Beach California 90807
ShORe Investigational Site Los Angeles California 95817
ShORe Investigational Site Mountain View California 94040
ShORe Investigational Site Palm Desert California 92211
ShORe Investigational site Pasadena California 91107
ShORe Investiagtional Site Poway California 92064
ShORe Investigational Site Redlands California 92373
ShORe Investigational Site Sacramento California 95817
ShORe Investigational Site Santa Ana California 92705
ShORe Investigational Site Torrance California 90503
ShORe Investigational Site Colorado Springs Colorado 80909
ShORe Investigational Site Denver Colorado 80206
ShORe Investigational Site Lakewood Colorado 80228
ShORe Investigational Site Longmont Colorado 80503
ShORe Investigational Site Clearwater Florida 33761
ShORe Investigational Site Fort Lauderdale Florida 33308
ShORe Investigational Site Fort Myers Florida 33912
ShORe Investigational Site Gainesville Florida 32607
ShORe Investigational Site Lakeland Florida 33805
ShORe Investigational Site Pensacola Florida 32503
ShORe Investigational Site Pinellas Park Florida 33782
ShORe Investigational Site Temple Terrace Florida 33617
ShORe Investigational Site Augusta Georgia 30909
ShORe Investigational Site Sandy Springs Georgia 30328
ShORe Investigational Site Lemont Illinois 60439
ShORe Investigational Site Indianapolis Indiana 46290
ShORe Investigational Site Baltimore Maryland 21209
ShORe Investigational Site Baltimore Maryland 21237
ShORe Investigational Site Hagerstown Maryland 21740
ShORe Investigational Site Towson Maryland 21204
ShORe Investigational Site Springfield Massachusetts 01107
ShORe Investigational Site Minneapolis Minnesota 55416
ShORe Investigational Site St Louis Missouri 63108
ShORe Investigational Site Reno Nevada 89502
ShORe Investigational Site Bloomfield New Jersey 07003
ShORe Investigational Site Toms River New Jersey 08755
ShORe Investigational Site Hauppauge New York 11021
ShORe Investigational Site Liverpool New York 13088
ShORe Investigational Site Wake Forest North Carolina 27587
ShORe Investigational Site Fargo North Dakota 58104
ShORe Investigational Site Edmond Oklahoma 73013
ShORe Investigational Site Tulsa Oklahoma 74114
ShORe Investigational Site Eugene Oregon 97401
ShORe Investigational Site Portland Oregon 97225
ShORe Investigational Site Portland Oregon 97239
ShORe Investigational Site Salem Oregon 97302
ShORe Investigational Site Erie Pennsylvania 16507
ShORe Investigational Site Beaufort South Carolina 29902
ShORe Investigational Site Ladson South Carolina 29456
ShORe Investigational Site Nashville Tennessee 37203
ShORe Investigational Site Arlington Texas 76012
ShORe Investigational Site Austin Texas 78705
ShORe Investigational Site Austin Texas 78731
ShORe Investigational Site Bellaire Texas 77401
ShORe Investigational Site Dallas Texas 75231
ShORe Investigational Site Houston Texas 77030
ShORe Investigational Site Katy Texas 77494
ShORe Investigational Site McAllen Texas 78503
ShORe Investigational Site San Antonio Texas 78240
ShORe Investigational Site San Antonio Texas 78251
ShORe Investigational Site San Antonio Texas 78340
ShORe Investigational Site Tyler Texas 75701
ShORe Investigational Site Willow Park Texas 76087
ShORe Investigational Site Salt Lake City Utah 84107
ShORe Investigational Site Charlottesville Virginia 22903
ShORe Investigational Site Lynchburg Virginia 24502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04757610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04757610 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →